lipstick being manufactured on production line

The PFAS Threshold Trap: Why “Intentional Use” is No Longer the Standard for Cosmetics Compliance

May 11, 2026

Written by Registrar Corp


For years, many global cosmetics brands have operated under a comfortable regulatory assumption: if they do not intentionally add “forever chemicals” (PFAS) to their formulations, they are insulated from the growing wave of PFAS restrictions. This “intentional use” standard allowed brands to rely on simple qualitative checks and marketing-led ingredient exclusions.

However, a fundamental shift in enforcement is occurring. Regulatory bodies—led by the rigorous new French Decree—are moving away from banning “intentional use” and toward enforcing strict residual concentration thresholds. This shift transforms PFAS from a marketing concern into a high-stakes technical liability.

The longevity and ubiquity of these chemicals mean they are no longer just “ingredients” you choose; they are contaminants you must actively manage.

The French Precursor: A New Global Benchmark

While many regions are still evaluating their approach to PFAS, France has already set the pace with a decree that serves as a regulatory precursor to upcoming EU-wide restrictions under REACH. As of January 1, 2026, the French market is enforcing three distinct technical compliance thresholds that aim to distinguish trace contamination from intentional use:

  1. 25 ppb (parts per billion) for individual PFAS.
  2. 250 ppb for the sum of targeted PFAS.
  3. 50 ppm (parts per million) for total PFAS, including polymers (total fluorine/overall approach).

Exceeding any one of these thresholds triggers non-compliance. This is no longer about checking an ingredient list; it is about the invisible reality of trace contamination. PFAS can enter your products via multiple, undocumented vectors: raw material processing aids, cross-contamination in water sources, or even migration from the non-stick coatings and recycled plastics used in your primary packaging.

Because importation is legally equivalent to “placing on the market,” a single shipment exceeding these parts-per-billion levels can lead to immediate customs blocking, market surveillance actions, and mandatory recalls. These enforcement actions don’t just destroy a single batch; they damage your brand’s reputation across the entire EU and can trigger a ripple effect of scrutiny from other global regulators.

The Myth of the “Safe” Ingredient List

A common objection among regulatory managers is that “PFAS aren’t banned as a class in the EU yet.” While technically true under the current REACH framework, this is a dangerous excuse that creates a false sense of security. The proposed REACH restriction covers over 10,000 substances. Waiting for a class-wide ban to take effect before auditing your supply chain is a recipe for operational paralysis.

The risk doesn’t just surface during routine operations; it surfaces during moments of extreme stress—specifically during the 12-month stock depletion periods allowed for existing inventory manufactured before January 2026. To utilize these transitional provisions and avoid a total write-off of your existing stock, your manufacturing dates must be robustly documented.

The French authorities will require more than a simple timestamp. You must be able to produce batch records, release documentation, and clear traceability data that proves the product was manufactured within the legal window. If your current record-keeping relies on fragmented R&D logs, manual spreadsheets, or incomplete supplier visibility, proving compliance during a snap audit or customs inspection becomes nearly impossible.

Moving from Reactive Testing to Proactive Management

Most testing providers focus on the “after-the-fact” result: they tell you if a product has already failed. But for a brand managing hundreds of SKUs across multiple jurisdictions—from New Zealand’s broad 2027 phase-out to the evolving US state-level bans—testing alone is not a strategy; it is an expense that only identifies problems when it is often too late to fix them.

The complexity of these ppb-level thresholds requires a centralized “Source of Truth.” You need to move beyond “Yes/No” ingredient lists to a system where you can:

  • Track Trace Contamination Data: Manage specific concentration data at the raw material level across your entire portfolio.
  • Ensure Batch-Level Traceability: Maintain the rigorous documentation—such as batch-specific supplier declarations and analytical reports—required to survive the 2026 French transition.
  • Neutralize Information Asymmetry: Verify and cross-reference supplier declarations with structured data, ensuring that your “PFAS-Free” claim is backed by a defensible digital audit trail that stands up to regulatory surveillance.

The Strategic Advantage of Product Lifecycle Management

Compliance is no longer a “bolt-on” activity to be handled at the end of the development cycle. In the PFAS era, where contamination can occur at any stage of the supply chain, regulatory oversight must be cemented into your Good Manufacturing Practices (GMP).

This is why leading cosmetics brands are moving away from the “fire-drill” approach of manual tracking and toward specialized software like Cosmetri. By integrating your product management and GMP requirements into a single, automated platform, you remove the “cognitive overload” of tracking 10,000+ substances across shifting global thresholds. You move from a state of constant regulatory anxiety to one of predictable, market-ready stability.

In a market where the cost of a single “forever chemical” error can mean the permanent loss of a major territory and a public-facing recall, the most valuable asset you have is not just a lab result—it is certainty.

Master Your Cosmetics Compliance and GMP with Cosmetri

Author


Registrar Corp

World's Leading FDA Compliance Experts

Registrar Corp thrives on the collective expertise of over 200 professionals, including former FDA officials and experienced industry specialists. Our team of regulatory specialists is our greatest asset, offering deep insights into the latest and longstanding FDA regulations. With our simple, straightforward, and actionable articles, you can navigate the complex regulatory landscape with ease.

Related Article


Subscribe To Our News Feed

To top
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.